Sexual health testing guide · 2026
These three organisms appear on almost every multiplex panel sold in Bangkok, and a positive result is the single most common reason people are prescribed antibiotics they do not need.
By MedEx · Updated September 2026 · Approx. 8-minute read
Quick answer
Ureaplasma parvum, Ureaplasma urealyticum and Mycoplasma hominis are commonly carried in the genital tract of healthy, sexually active adults without causing disease. They appear on most multiplex PCR panels, and a positive result is frequently misread as an STI diagnosis. Major guidelines do not recommend screening asymptomatic people for these organisms, and do not recommend treating an incidental positive. They may contribute to symptoms in specific situations — persistent urethritis after other causes have been excluded, or in certain obstetric and immunocompromised contexts — and that is when a clinician may act on the result.
In this guide
- Why a positive result usually is not a diagnosis
- Do not confuse these with M. genitalium
- When these organisms may matter
- What to do with an incidental positive
| Carriage | Common in healthy adults; frequently part of normal genital flora |
|---|---|
| Screening | Not recommended for asymptomatic people by major guidelines |
| May matter when | Persistent urethritis with other causes excluded; specific obstetric or immunocompromised settings |
| Distinct from | Mycoplasma genitalium, which is a recognised pathogen |
| Price | Listed on the MedEx STD and STI testing page and the lab test catalogue |
| If positive | Same-day doctor consultation for treatment and partner advice |
Why a positive result usually is not a diagnosis
Colonisation rates in healthy, asymptomatic adults are high — studies have found Ureaplasma species in a large proportion of sexually active people with no symptoms and no disease. Ureaplasma parvum in particular is very commonly carried and has the weakest association with symptoms of the three.
Because PCR is highly sensitive, it detects this carriage reliably. The result is a positive line on a report that looks identical to a chlamydia positive but means something entirely different.
The distinction matters clinically. Treating carriage exposes you to antibiotics without benefit, disturbs normal flora, and contributes to resistance. It also risks anchoring on the wrong explanation while the actual cause of symptoms goes unaddressed. This is the central point of the STI PCR panel guide.
Do not confuse these with M. genitalium
| Mycoplasma genitalium | A recognised pathogen. Causes urethritis, cervicitis and PID. Testing indicated when symptomatic. Resistance-guided treatment recommended. |
|---|---|
| Mycoplasma hominis | Frequently commensal. Associated with bacterial vaginosis and, in specific settings, with pelvic infection. Not a screening target. |
| Ureaplasma urealyticum | Sometimes implicated in non-gonococcal urethritis, but also commonly carried. Interpret only with symptoms. |
| Ureaplasma parvum | Very commonly carried. Weakest association with disease of the group. |
The similarity of the names causes real confusion. If a report shows “Mycoplasma” positive, check which species before drawing any conclusion — see the M. genitalium guide for the one that does require action.
Got a confusing panel result? Have it interpreted before taking antibiotics.
When these organisms may matter
Persistent non-gonococcal urethritis. Where symptoms continue after chlamydia, gonorrhoea, M. genitalium and trichomonas have been excluded and treated as appropriate, U. urealyticum is sometimes considered as a contributing cause. This is a clinical judgement, not an automatic step.
Bacterial vaginosis. M. hominis is frequently found alongside BV-associated flora. The treatment target is the BV itself rather than the organism on the panel.
Obstetric and neonatal settings. There is an association with chorioamnionitis and preterm birth in some studies, and these organisms can cause neonatal infection. Management in pregnancy is a specialist decision.
Immunocompromised patients. Invasive infection, including joint and respiratory infection, occurs but is uncommon and clinically obvious.
None of these is a reason for a well person with no symptoms to be treated for an incidental positive.
What to do with an incidental positive
- Check whether you have symptoms. If not, in most cases no action is needed.
- Check what else was on the panel. A positive for chlamydia, gonorrhoea, trichomonas or M. genitalium is the finding that matters and should be treated.
- If you do have symptoms, look for the more likely cause first — including urinary tract infection, bacterial vaginosis, candida, and non-infectious causes such as irritation from products or friction.
- Discuss with a clinician before accepting antibiotics. Ask specifically what the treatment is intended to achieve and how you will know whether it worked.
- Do not treat partners for an incidental commensal positive; partner treatment applies to the recognised pathogens.
A short doctor consultation to review the report is usually more valuable than a prescription.
Frequently asked questions
Is Ureaplasma an STI?
It is sexually transmissible but is commonly carried by healthy adults without causing disease. Major guidelines do not classify it as a routine screening target and do not recommend treating an incidental positive in someone without symptoms.
Should I treat a positive Ureaplasma result?
Usually not, if you have no symptoms. Treatment may be considered where urethritis persists after chlamydia, gonorrhoea, M. genitalium and trichomonas have been excluded, but that is a clinical judgement.
What is the difference between Mycoplasma hominis and Mycoplasma genitalium?
M. genitalium is a recognised pathogen causing urethritis, cervicitis and pelvic inflammatory disease, and warrants resistance-guided treatment. M. hominis is frequently commensal and is not a screening target. The similar names cause frequent confusion.
Do my partners need treating if I test positive for Ureaplasma?
Not for an incidental positive in the absence of symptoms. Partner treatment applies to recognised pathogens such as chlamydia, gonorrhoea, trichomonas and M. genitalium.
Can Ureaplasma cause infertility?
The evidence is not strong enough to support routine testing or treatment for this reason. Where fertility is the concern, a structured fertility assessment is more useful than treating a commensal organism.
Why is it on the panel if it does not need treating?
Multiplex panels are designed to detect a broad range of organisms, and these are technically detectable. Their presence on a panel is not the same as a recommendation to test or treat.
Testing for the organisms that actually need treating.
Sources and further reading
- CDC Sexually Transmitted Infections Treatment Guidelines
- BASHH UK national guidelines
- MedEx STD and STI testing service
Medical disclaimer: This article is general health information and does not replace medical advice, diagnosis or treatment. Laboratory reference ranges differ between laboratories and results must be interpreted alongside your symptoms, medicines and medical history. Speak with a qualified clinician before starting, stopping or changing any treatment. Service details, inclusions and prices can change — confirm them with MedEx before booking.


